Kasai Portoenterostomy Timing and Outcomes in Biliary Atresia
NCT07328204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-02-06
Summary
What is this study about? This study aims to find out the best timing for a major surgery called Kasai portoenterostomy (Kasai surgery) in infants with a liver disease called biliary atresia. The investigators want to see if having the surgery earlier leads to better long-term health for the baby's own liver.
Why is this important? Doctors know that early surgery is important, but it's unclear exactly how early is best. Some babies have surgery within the first month, others within 2-3 months. The investigators want to carefully compare different time windows to see which one gives the child the best chance to keep their own liver healthy and avoid a liver transplant.
How will the study work?
This is an observational study. The investigators will not change the treatment any child receives. The investigators will enroll about 200 infants from 4-5 children's hospitals in China. The investigators will simply group the infants based on their actual age at surgery:
Group 1: Surgery at 28 days old or younger.
Group 2: Surgery between 29 and 60 days old.
Group 3: Surgery between 61 and 90 days old.
Group 4: Surgery between 91 and 120 days old.
The investigators will then follow all children for 2 years after their surgery.
What will the investigators measure? The main thing the investigators want to see is how many children in each group are alive with their own liver working well 2 years after surgery (without needing a transplant). The investigators will also check many other health factors, like liver function tests, nutrition, growth, complications (like infections), and the costs of care.
What is the goal? The results of this study will help doctors and families make better, evidence-based decisions about the best time to perform this critical surgery for babies with biliary atresia.
Conditions
- Biliary Atresia
Interventions
- PROCEDURE
-
Kasai portoenterostomy
All participants in this observational study receive the standard-of-care surgical procedure, Kasai portoenterostomy (KPE). There is no study-specific intervention. The sole factor that distinguishes the four study cohorts is the natural timing of this standard surgery in the clinical course, which serves as the exposure variable for comparison. The cohorts are defined as follows: Cohort 1: KPE performed at or before 28 days of age. Cohort 2: KPE performed between 29 and 60 days of age. Cohort 3: KPE performed between 61 and 90 days of age. Cohort 4: KPE performed between 91 and 120 days of age. Participants are grouped based on their actual age at surgery in real-world practice. The study aims to compare long-term outcomes across these pre-defined surgical timing strata.
Sponsors & Collaborators
-
The Children's Hospital of Zhejiang University School of Medicine
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-01
- Primary Completion
- 2025-12-01
- Completion
- 2025-12-01
Countries
- China
Study Locations
More Related Trials
-
Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension
NCT06970509 ·Status: RECRUITING
-
Mechanism of TIPS to Improve Sarcopenia
NCT06794853 ·Status: RECRUITING
-
Autologous BMNC Infusion for Liver Cirrhosis in Children With BA
NCT05517317 ·Status: COMPLETED ·Phase: PHASE1
-
Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy
NCT02505152 ·Status: UNKNOWN ·Phase: NA
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035 ·Status: RECRUITING
-
Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein
NCT00993941 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical,Endoscopic and Radiological Assessment of Portal Hypertension in Children With Chronic Liver Diseases
NCT06097715 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis
NCT05181332 ·Status: UNKNOWN
-
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Via Hepatic Artery in Patients With Liver Cirrhosis
NCT00976287 ·Status: UNKNOWN ·Phase: PHASE2
-
The Influence of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy
NCT03825848 ·Status: UNKNOWN ·Phase: NA
-
A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism
NCT05055713 ·Status: UNKNOWN ·Phase: NA
-
Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
NCT02335580 ·Status: COMPLETED
-
Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis
NCT01223664 ·Status: UNKNOWN ·Phase: PHASE2
-
Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut.
NCT07144501 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis
NCT06122753 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network
NCT04251286 ·Status: UNKNOWN
-
Gastric Antral Vascular Ectasia in Patients With Cirrhosis: Risk-factors and Associations.
NCT05690750 ·Status: UNKNOWN
-
Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites
NCT03172273 ·Status: UNKNOWN ·Phase: NA
-
Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension
NCT01642446 ·Status: COMPLETED ·Phase: NA
-
The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis:A Multicenter RCT
NCT02630095 ·Status: UNKNOWN ·Phase: PHASE4
-
Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis
NCT06122792 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome
NCT05459883 ·Status: COMPLETED
-
The Treatment of Hepatocirrhosis and Portal Hypertension
NCT02778425 ·Status: COMPLETED ·Phase: NA
-
The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis
NCT04823780 ·Status: COMPLETED
-
Early TIPS in Patients With Liver Cirrhosis and Ascites
NCT06576934 ·Status: RECRUITING ·Phase: NA